Historique
Article de Périodique
Transdermal buprenorphine to switch patients from higher dose methadone to buprenorphine without severe withdrawal symptoms : Letter to the editor (2011)
Auteur(s) :
HESS, M. ;
BOESCH, L. ;
LEISINGER, R. ;
STOHLER, R.
Année
2011
Page(s) :
480-481
Langue(s) :
Anglais
Refs biblio. :
10
Domaine :
Drogues illicites / Illicit drugs
Thésaurus géographique
SUISSE
Thésaurus mots-clés
METHADONE
;
BUPRENORPHINE
;
TRAITEMENT DE MAINTENANCE
;
SYNDROME DE SEVRAGE
Résumé :
Buprenorphine has some advantages over methadone, such as missing evidence for QTc prolongation, possible alternate day dosing, limited respiratory depression, and a lower risk of overdosing. A transition from methadone to buprenorphine can become necessary for many reasons. There is presently no standard protocol for transition from high-dose methadone to buprenorphine.
[…]
The aim of this study was, therefore, to examine methods that could be used to give patients in higher dose methadone treatment the possibility to switch to buprenorphine without a prior reduction of the dose, decrease withdrawal discomfort, and keep the transfer time period as short as possible. [Extracts]
[…]
The aim of this study was, therefore, to examine methods that could be used to give patients in higher dose methadone treatment the possibility to switch to buprenorphine without a prior reduction of the dose, decrease withdrawal discomfort, and keep the transfer time period as short as possible. [Extracts]
Affiliation :
University Department of General and Social Psychiatry, Psychiatric University Hospital, Zurich, Switzerland